CRG | IMPaCT T2D Symposium: Genome Sequencing and Precision Medicine for Type 2 Diabetes

ALL_TABS

About

The CRG | IMPaCT T2D Symposium: Genome Sequencing and Precision Medicine for Type 2 Diabetes will be celebrated on November 17th -18th, 2022 at the Centre of Genomic Regulation (CRG) in Barcelona.

The Symposium is an event organized by the CRG on occasion of a new recent initiative funded by the Spanish Ministry of Science and Innovation, known as IMPaCT T2D, to sequence whole genomes from a cohort of patients with type 2 diabetes. Its purpose is to bring together experts in genomics and precision medicine from academic and private sectors and while there is a significant focus on diabetes, some sessions will cover other areas of genomic medicine.

Organising Committee: Urko Marigorta, Arcadi Navarro, Jorge Ferrer, Silvia Bonas-Guarch, Jesús Blanco, Josep Franch and Sara Guerrero

Registration deadline extended until 15th November 2022. Register HERE.

Supported by:

Speakers

Jose Florez

University of Harvard

University of Exeter

University of Exeter

AstraZeneca

Vrije Universiteit Amsterdam

Marylyn D. Ritchie

University of Pennsylvania

Peter Visscher

University of Queensland

Eleftheria Zeggini

Helmholtz Zentrum München

Mònica Bayés

Centro Nacional de Análisis Genómico (CNAG-CRG)

Sílvia Bonàs-Guarch

Centre for Genomic Regulation

Jorge Ferrer

Centre for Genomic Regulation

Program

Day 1
Thursday, 17th November

15.30 IMPaCT, a Spanish Precision Medicine Initiative

Chair: Dídac Mauricio

Welcome

Genomics in the IMPaCT Spanish Personalized Medicine Infrastructure
Mónica Bayes, CNAG

The IMPaCT-T2D Initiative
Silvia Bonàs-Guarch, Center for Genomic Regulation

16.30 COFFEE BREAK

17.00 Keynote lectures

Chair: Urko Martínez

Human Genetics in T2D Drug Discovery and Development: A Tale from AstraZeneca’s Genomics Initiative
Slavé Petrovski, Centre for Genomics Research, AstraZeneca

Embracing the complexity of complex disease
Marylyn D. Ritchie, University of Pennsylvania

18.00 END OF FIRST DAY

Day 2
Friday, 18th November

9.00 Genomic insights into Mendelian Diabetes

Chair: Luis Castaño

Modeling non-coding genome defects underlying diabetes
Jorge Ferrer, Center for Genomic Regulation

Correctly identifying and treating pathogenic coding variants causing monogenic diabetes
Andrew Hattersley, University of Exeter

10.20 COFFEE BREAK

10.50 Leveraging complex trait genetics for predictive medicine

Chair: Arcadi Navarro

The genetic of human height, a model complex trait
Peter Visscher, University of Queensland

Translational genomics of cardiometabolic traits
Eleftheria Zeggini, Helmholtz Zentrum München

From GWAS to function - strategies to gain mechanistic disease insight
Danielle Posthuma, Vrije Universiteit Amsterdam

12.50 LUNCH

14.00 Genomics and precision medicine for common forms of diabetes

Chair: Ana M. Wägner

Type 1 diabetes genetic risk scores for improved classification and prediction of diabetes
Richard Oram, University of Exeter

Towards precision medicine in diabetes: using genetics to understand disease heterogeneity
José Flórez, University of Harvard

15.20 Closing

15.30 END OF THE SYMPOSIUM

Registration

REGISTRATION FEE
Registration fee includes admission to all sessions, coffee breaks and lunch on the second day of the conference.
Conference registration fee does not include any travel and accommodation expenses.

General: 150 euros (21% VAT included)

CANCELLATION POLICY
In case of any cancellation or non-attendance, unfortunately, the registration fees are not refundable.

Registration form

REGISTRATION DEADLINE EXTENDED: 15th November 2022

Contact and Venue

Contact

Sara Guerrero
Project Manager
CRG-Centre for Genomic Regulation

Venue

PRBB Auditorium
CRG – Centre for Genomic Regulation
Dr. Aiguader, 88
08003 Barcelona, Spain
www.crg.eu

You are here

CRG | IMPaCT T2D Symposium: Genome Sequencing and Precision Medicine for Type 2 Diabetes